Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study.
Sun Ju ChungMatilde CalopaMaria Gabriella CeravoloNicola TambascoAngelo AntoniniKallol Ray ChaudhuriWeining Z RobiesonOlga Sánchez-SoliñoCindy ZadikoffMan JinLuigi M BarbatoPublished in: Parkinson's disease (2022)
There were no significant differences between LCIG versus OMT in NMSS or PDSS-2; both LCIG and OMT groups significantly improved from baseline. AEs were consistent with the known safety profile.